Designed 13 Mer Hairpin-peptide Arrests Insulin and Inhibits Its Aggregation: Role of OH-π Interactions Between Water and Hydrophobic Amino Acids

Overview

Journal RSC Adv

Publisher Royal Society of Chemistry

Specialty Chemistry

Date 2022 May 2

PMID 35497136

Authors

Meghomukta Mukherjee

Nilanjan Banerjee

Subhrangsu Chatterjee

Affiliations

Soon will be listed here.

Abstract

: Protein aggregation in the cellular systems can be highly fatal causing a series of diseases including neurodegenerative diseases like ALS, Alzheimer, Prion Diseases, Parkinson's and other diseases like type II diabetes. To date, there is no crucial mechanism invented that shows how a protein molecule unfolds or misfolds. Insulin fibrillation in type II diabetes is an alarming event that brings every year deaths of millions of people around the globe. Pharmaceutical companies are still in the cultivation of finding newer therapeutic agents which halt/impede insulin aggregation to combat diabetes II and improve the patient's life expectancy. : Here in this report, we have engineered four short 13 mer peptides (N-term-DMYY- N-term-DITT- N-term-DIFF- N-term-KVYY-) which target monomeric insulin in its globular form. The designed peptides are found to be non-cytotoxic in human HEK293 cells. Among these four peptides, only DITT- showed complete inhibition of insulin fibrillation, whereas DIFF- and DIYY- and KVYY- lost their functionality to impede insulin aggregation to a great extent. High-resolution multi-dimensional NMR experiments portrayed the 13 mer sequences of peptides in the beta-hairpin forms. A series of biophysical techniques like CD, ThT assay, DLS, SEM, ITC, size-exclusion chromatography, and molecular dynamics simulation strongly evidenced inhibition of insulin fibrillation by N-term-DITT- compared to those by the other peptides. : Here we tried to unravel how DITT- could impede insulin fibrillation.

References

Khurana R, Ionescu-Zanetti C, Pope M, Li J, Nielson L, Ramirez-Alvarado M . A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy. Biophys J. 2003; 85(2):1135-44. PMC: 1303232. DOI: 10.1016/S0006-3495(03)74550-0. View

Ivanova M, Sievers S, Sawaya M, Wall J, Eisenberg D . Molecular basis for insulin fibril assembly. Proc Natl Acad Sci U S A. 2009; 106(45):18990-5. PMC: 2776439. DOI: 10.1073/pnas.0910080106. View

Banerjee V, Kar R, Datta A, Parthasarathi K, Chatterjee S, Das K . Use of a small peptide fragment as an inhibitor of insulin fibrillation process: a study by high and low resolution spectroscopy. PLoS One. 2013; 8(8):e72318. PMC: 3756998. DOI: 10.1371/journal.pone.0072318. View

Wang W, Hecht M . Rationally designed mutations convert de novo amyloid-like fibrils into monomeric beta-sheet proteins. Proc Natl Acad Sci U S A. 2002; 99(5):2760-5. PMC: 122421. DOI: 10.1073/pnas.052706199. View

Walsh D, Klyubin I, Fadeeva J, Cullen W, Anwyl R, Wolfe M . Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002; 416(6880):535-9. DOI: 10.1038/416535a. View

Dobson C . Protein folding and misfolding. Nature. 2003; 426(6968):884-90. DOI: 10.1038/nature02261. View

Hua Q, Weiss M . Comparative 2D NMR studies of human insulin and des-pentapeptide insulin: sequential resonance assignment and implications for protein dynamics and receptor recognition. Biochemistry. 1991; 30(22):5505-15. DOI: 10.1021/bi00236a025. View

Hua Q, Weiss M . Mechanism of insulin fibrillation: the structure of insulin under amyloidogenic conditions resembles a protein-folding intermediate. J Biol Chem. 2004; 279(20):21449-60. DOI: 10.1074/jbc.M314141200. View

Sharp J, Forrest J, Jones R . Surface denaturation and amyloid fibril formation of insulin at model lipid-water interfaces. Biochemistry. 2002; 41(52):15810-9. DOI: 10.1021/bi020525z. View

10.

Zaman M, Khan M, Zakariya S, Nusrat S, Meeran S, Alam P . Amino group of salicylic acid exhibits enhanced inhibitory potential against insulin amyloid fibrillation with protective aptitude toward amyloid induced cytotoxicity. J Cell Biochem. 2018; 119(5):3945-3956. DOI: 10.1002/jcb.26538. View

11.

Pierce B, Wiehe K, Hwang H, Kim B, Vreven T, Weng Z . ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers. Bioinformatics. 2014; 30(12):1771-3. PMC: 4058926. DOI: 10.1093/bioinformatics/btu097. View

12.

Kachooei E, Moosavi-Movahedi A, Khodagholi F, Ramshini H, Shaerzadeh F, Sheibani N . Oligomeric forms of insulin amyloid aggregation disrupt outgrowth and complexity of neuron-like PC12 cells. PLoS One. 2012; 7(7):e41344. PMC: 3407202. DOI: 10.1371/journal.pone.0041344. View

13.

Yu N, Liu C . Laser Raman spectra of native and denatured insulin in the solid state. J Am Chem Soc. 1972; 94(9):3250-1. DOI: 10.1021/ja00764a068. View

14.

Westermark P, Wilander E . Islet amyloid in Type 2 (non-insulin-dependent) diabetes is related to insulin. Diabetologia. 1983; 24(5):342-6. DOI: 10.1007/BF00251821. View

15.

Rajamani D, Thiel S, Vajda S, Camacho C . Anchor residues in protein-protein interactions. Proc Natl Acad Sci U S A. 2004; 101(31):11287-92. PMC: 509196. DOI: 10.1073/pnas.0401942101. View

16.

Wang J, Wolf R, Caldwell J, Kollman P, Case D . Development and testing of a general amber force field. J Comput Chem. 2004; 25(9):1157-74. DOI: 10.1002/jcc.20035. View

17.

Brange J, Andersen L, Laursen E, Meyn G, Rasmussen E . Toward understanding insulin fibrillation. J Pharm Sci. 1997; 86(5):517-25. DOI: 10.1021/js960297s. View

18.

Yu N, Liu C, OShea D . Laser Raman spectroscopy and the conformation of insulin and proinsulin. J Mol Biol. 1972; 70(1):117-32. DOI: 10.1016/0022-2836(72)90167-2. View

19.

Maier J, Martinez C, Kasavajhala K, Wickstrom L, Hauser K, Simmerling C . ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. J Chem Theory Comput. 2015; 11(8):3696-713. PMC: 4821407. DOI: 10.1021/acs.jctc.5b00255. View

20.

Chiti F, Webster P, Taddei N, Clark A, Stefani M, Ramponi G . Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci U S A. 1999; 96(7):3590-4. PMC: 22338. DOI: 10.1073/pnas.96.7.3590. View